GEMCITABINE HCL (GEMCITABINE HCL)
- Adenocarcinoma of pancreas
- Malignant neoplasm of fallopian tube
- Malignant neoplasm of the ovary
- Metastatic breast carcinoma
- Non-small cell lung cancer
- Primary malignant neoplasm of peritoneum
gemcitabine 1 gram/26.3 mL (38 mg/mL) intravenous solution
- Dosage information is not available
gemcitabine 100 mg/mL intravenous solution
- Dosage information is not available
gemcitabine 2 gram/52.6 mL (38 mg/mL) intravenous solution
- Dosage information is not available
gemcitabine 200 mg/5.26 mL (38 mg/mL) intravenous solution
- Dosage information is not available
1 gram intravenous solution
- Dosage information is not available
2 gram intravenous solution
- Dosage information is not available
200 mg intravenous solution
- Dosage information is not available
gemcitabine 1 gram intravenous solution
- Dosage information is not available
gemcitabine 2 gram intravenous solution
- Dosage information is not available
gemcitabine 200 mg intravenous solution
- Dosage information is not available
Adenocarcinoma of pancreas
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weekly
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyfor 3 consecutive weeks of a 4 week schedule
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyon days 1, 8 and 15 of a 28 day cycle
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyfor 7 weeks followed by a 1-week rest period
Malignant neoplasm of fallopian tube
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weekly
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyfor 3 consecutive weeks of a 4 week schedule
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyon days 1, 8 and 15 of a 28 day cycle
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyon days 1 and 8 of a 21 day cycle
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route on days 1 and 8 of a 21 day cycle
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyfor 7 weeks followed by a 1-week rest period
Malignant neoplasm of the ovary
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyon days 1 and 8 of a 21 day cycle
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route on days 1 and 8 of a 21 day cycle
Metastatic breast carcinoma
- Infuse 1,250 mg/m2 over 30 minute(s) by intravenous route on days 1 and 8 of a 21 day cycle
Non-small cell lung cancer
- Infuse 1,250 mg/m2 over 30 minute(s) by intravenous route on days 1 and 8 of a 21 day cycle
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyon days 1, 8 and 15 of a 28 day cycle
Primary malignant neoplasm of peritoneum
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weekly
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyfor 3 consecutive weeks of a 4 week schedule
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyon days 1, 8 and 15 of a 28 day cycle
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyon days 1 and 8 of a 21 day cycle
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route on days 1 and 8 of a 21 day cycle
- Infuse 1,000 mg/m2 over 30 minute(s) by intravenous route once weeklyfor 7 weeks followed by a 1-week rest period
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- clozapine
- Clozaril
- deferiprone
- Fazaclo
- Ferriprox
- Versacloz
Severe
Moderate
- None
- Acute respiratory distress syndrome
- Hemolytic uremic syndrome
- Interstitial pneumonitis
- Lactating mother
Contraindicated
- Anemia
- Bone marrow depression
- Capillary leak syndrome
- Drug-induced hepatitis
- Kidney disease with reduction in GFR
- Neutropenic disorder
- Posterior reversible encephalopathy syndrome
- Pregnancy
- Thrombocytopenic disorder
Severe
Moderate
- Alcoholic liver damage
- Hepatic cirrhosis
- Hepatic metastases
- Hepatitis
- Infection
GEMCITABINE HCL (GEMCITABINE HCL)
- Adenocarcinoma of pancreas
- Malignant neoplasm of fallopian tube
- Malignant neoplasm of the ovary
- Metastatic breast carcinoma
- Non-small cell lung cancer
- Primary malignant neoplasm of peritoneum
- Abnormal hepatic function tests
- Anemia
- Dyspnea
- Hematuria
- Hypomagnesemia
- Leukopenia
- Neutropenic disorder
- Skin rash
- Thrombocytopenic disorder
- Alopecia
- Constipation
- Diarrhea
- Edema
- Fatigue
- Fever
- Flu-like symptoms
- Hyperglycemia
- Nausea
- Peripheral edema
- Peripheral sensory neuropathy
- Proteinuria
- Vomiting
More Frequent
Severe
Less Severe
- Bronchospastic pulmonary disease
- Hemorrhage
- Hyperbilirubinemia
- Hypocalcemia
- Peripheral motor neuropathy
- Systemic infection
- Anorexia
- Arthralgias
- Drowsy
- General weakness
- Hyperhidrosis
- Injection site sequelae
- Insomnia
- Malaise
- Paresthesia
- Rhinitis
- Stomatitis
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal desquamation
- Acute myocardial infarction
- Acute respiratory distress syndrome
- Anaphylaxis
- Bacterial sepsis
- Bullous dermatitis
- Capillary leak syndrome
- Cardiac arrhythmia
- Cellulitis
- Cerebrovascular accident
- Chronic heart failure
- Eosinophilic pneumonia
- Gangrene
- Heart failure
- Hemolytic uremic syndrome
- Hepatic failure
- Hepatic veno-occlusive disease
- Hepatitis
- Hypersensitivity drug reaction
- Hypertension
- Interstitial pneumonitis
- Kidney disease with reduction in GFR
- Posterior reversible encephalopathy syndrome
- Pulmonary edema
- Pulmonary fibrosis
- Radiation recall syndrome
- Renal failure
- Supraventricular arrhythmias
- Thrombotic thrombocytopenic purpura
- Vasculitis
Less Severe
- Pseudocellulitis
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Gemcitabine
Efficacy not demonstrated in pediatric trials of refractory leukemia , relapsed ALL or AML. Toxicity profile similar to adults.
- 1 Day – 18 Years
- Efficacy not demonstrated in pediatric trials of refractory leukemia , relapsed ALL or AML. Toxicity profile similar to adults.
Gemcitabine
- Severity Level:
D
- Additional Notes: Based on drug pharmacology developmental toxicity is possible.
Contraindicated
Gemcitabine
Avoid breastfeeding during treatment and for 1 week following last dose.
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Avoid breastfeeding during treatment and for 1 week following last dose. |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Gemcitabine
General-Grade 3 or 4 thrombocytopenia or neutropenia are more common in the elderly. Plasma clearance in the elderly (age 79) is slower resulting in a drug half life that is nearly twice that in young (age 29) patients. The manufacturer does not have any dosing guidelines in the elderly.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Adenocarcinoma of pancreas | |
C24.1 | Malignant neoplasm of ampulla of vater |
C25 | Malignant neoplasm of pancreas |
C25.0 | Malignant neoplasm of head of pancreas |
C25.1 | Malignant neoplasm of body of pancreas |
C25.2 | Malignant neoplasm of tail of pancreas |
C25.3 | Malignant neoplasm of pancreatic duct |
C25.4 | Malignant neoplasm of endocrine pancreas |
C25.7 | Malignant neoplasm of other parts of pancreas |
C25.8 | Malignant neoplasm of overlapping sites of pancreas |
C25.9 | Malignant neoplasm of pancreas, unspecified |
Malignant neoplasm of fallopian tube | |
C57.0 | Malignant neoplasm of fallopian tube |
C57.00 | Malignant neoplasm of unspecified fallopian tube |
C57.01 | Malignant neoplasm of right fallopian tube |
C57.02 | Malignant neoplasm of left fallopian tube |
Malignant neoplasm of the ovary | |
C56 | Malignant neoplasm of ovary |
C56.1 | Malignant neoplasm of right ovary |
C56.2 | Malignant neoplasm of left ovary |
C56.9 | Malignant neoplasm of unspecified ovary |
Metastatic breast carcinoma | |
C50 | Malignant neoplasm of breast |
C50.1 | Malignant neoplasm of central portion of breast |
C50.11 | Malignant neoplasm of central portion of breast, female |
C50.111 | Malignant neoplasm of central portion of right female breast |
C50.112 | Malignant neoplasm of central portion of left female breast |
C50.119 | Malignant neoplasm of central portion of unspecified female breast |
C50.12 | Malignant neoplasm of central portion of breast, male |
C50.121 | Malignant neoplasm of central portion of right male breast |
C50.122 | Malignant neoplasm of central portion of left male breast |
C50.129 | Malignant neoplasm of central portion of unspecified male breast |
C50.2 | Malignant neoplasm of upper-inner quadrant of breast |
C50.21 | Malignant neoplasm of upper-inner quadrant of breast, female |
C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
C50.22 | Malignant neoplasm of upper-inner quadrant of breast, male |
C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast |
C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast |
C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast |
C50.3 | Malignant neoplasm of lower-inner quadrant of breast |
C50.31 | Malignant neoplasm of lower-inner quadrant of breast, female |
C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
C50.32 | Malignant neoplasm of lower-inner quadrant of breast, male |
C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast |
C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
C50.4 | Malignant neoplasm of upper-outer quadrant of breast |
C50.41 | Malignant neoplasm of upper-outer quadrant of breast, female |
C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
C50.42 | Malignant neoplasm of upper-outer quadrant of breast, male |
C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast |
C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast |
C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
C50.5 | Malignant neoplasm of lower-outer quadrant of breast |
C50.51 | Malignant neoplasm of lower-outer quadrant of breast, female |
C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
C50.52 | Malignant neoplasm of lower-outer quadrant of breast, male |
C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast |
C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast |
C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
C50.6 | Malignant neoplasm of axillary tail of breast |
C50.61 | Malignant neoplasm of axillary tail of breast, female |
C50.611 | Malignant neoplasm of axillary tail of right female breast |
C50.612 | Malignant neoplasm of axillary tail of left female breast |
C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
C50.62 | Malignant neoplasm of axillary tail of breast, male |
C50.621 | Malignant neoplasm of axillary tail of right male breast |
C50.622 | Malignant neoplasm of axillary tail of left male breast |
C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
C50.8 | Malignant neoplasm of overlapping sites of breast |
C50.81 | Malignant neoplasm of overlapping sites of breast, female |
C50.811 | Malignant neoplasm of overlapping sites of right female breast |
C50.812 | Malignant neoplasm of overlapping sites of left female breast |
C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
C50.82 | Malignant neoplasm of overlapping sites of breast, male |
C50.821 | Malignant neoplasm of overlapping sites of right male breast |
C50.822 | Malignant neoplasm of overlapping sites of left male breast |
C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast |
C50.9 | Malignant neoplasm of breast of unspecified site |
C50.91 | Malignant neoplasm of breast of unspecified site, female |
C50.911 | Malignant neoplasm of unspecified site of right female breast |
C50.912 | Malignant neoplasm of unspecified site of left female breast |
C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
C50.92 | Malignant neoplasm of breast of unspecified site, male |
C50.921 | Malignant neoplasm of unspecified site of right male breast |
C50.922 | Malignant neoplasm of unspecified site of left male breast |
C50.929 | Malignant neoplasm of unspecified site of unspecified male breast |
Non-small cell lung cancer | |
C34 | Malignant neoplasm of bronchus and lung |
C34.0 | Malignant neoplasm of main bronchus |
C34.00 | Malignant neoplasm of unspecified main bronchus |
C34.01 | Malignant neoplasm of right main bronchus |
C34.02 | Malignant neoplasm of left main bronchus |
C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
Primary malignant neoplasm of peritoneum | |
C48.1 | Malignant neoplasm of specified parts of peritoneum |
C48.2 | Malignant neoplasm of peritoneum, unspecified |
C48.8 | Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum |
0-9 | A-Z |
---|---|
C24.1 | Malignant neoplasm of ampulla of vater |
C25 | Malignant neoplasm of pancreas |
C25.0 | Malignant neoplasm of head of pancreas |
C25.1 | Malignant neoplasm of body of pancreas |
C25.2 | Malignant neoplasm of tail of pancreas |
C25.3 | Malignant neoplasm of pancreatic duct |
C25.4 | Malignant neoplasm of endocrine pancreas |
C25.7 | Malignant neoplasm of other parts of pancreas |
C25.8 | Malignant neoplasm of overlapping sites of pancreas |
C25.9 | Malignant neoplasm of pancreas, unspecified |
C34 | Malignant neoplasm of bronchus and lung |
C34.0 | Malignant neoplasm of main bronchus |
C34.00 | Malignant neoplasm of unspecified main bronchus |
C34.01 | Malignant neoplasm of right main bronchus |
C34.02 | Malignant neoplasm of left main bronchus |
C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
C48.1 | Malignant neoplasm of specified parts of peritoneum |
C48.2 | Malignant neoplasm of peritoneum, unspecified |
C48.8 | Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum |
C50 | Malignant neoplasm of breast |
C50.1 | Malignant neoplasm of central portion of breast |
C50.11 | Malignant neoplasm of central portion of breast, female |
C50.111 | Malignant neoplasm of central portion of right female breast |
C50.112 | Malignant neoplasm of central portion of left female breast |
C50.119 | Malignant neoplasm of central portion of unspecified female breast |
C50.12 | Malignant neoplasm of central portion of breast, male |
C50.121 | Malignant neoplasm of central portion of right male breast |
C50.122 | Malignant neoplasm of central portion of left male breast |
C50.129 | Malignant neoplasm of central portion of unspecified male breast |
C50.2 | Malignant neoplasm of upper-inner quadrant of breast |
C50.21 | Malignant neoplasm of upper-inner quadrant of breast, female |
C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
C50.22 | Malignant neoplasm of upper-inner quadrant of breast, male |
C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast |
C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast |
C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast |
C50.3 | Malignant neoplasm of lower-inner quadrant of breast |
C50.31 | Malignant neoplasm of lower-inner quadrant of breast, female |
C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
C50.32 | Malignant neoplasm of lower-inner quadrant of breast, male |
C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast |
C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
C50.4 | Malignant neoplasm of upper-outer quadrant of breast |
C50.41 | Malignant neoplasm of upper-outer quadrant of breast, female |
C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
C50.42 | Malignant neoplasm of upper-outer quadrant of breast, male |
C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast |
C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast |
C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
C50.5 | Malignant neoplasm of lower-outer quadrant of breast |
C50.51 | Malignant neoplasm of lower-outer quadrant of breast, female |
C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
C50.52 | Malignant neoplasm of lower-outer quadrant of breast, male |
C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast |
C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast |
C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
C50.6 | Malignant neoplasm of axillary tail of breast |
C50.61 | Malignant neoplasm of axillary tail of breast, female |
C50.611 | Malignant neoplasm of axillary tail of right female breast |
C50.612 | Malignant neoplasm of axillary tail of left female breast |
C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
C50.62 | Malignant neoplasm of axillary tail of breast, male |
C50.621 | Malignant neoplasm of axillary tail of right male breast |
C50.622 | Malignant neoplasm of axillary tail of left male breast |
C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
C50.8 | Malignant neoplasm of overlapping sites of breast |
C50.81 | Malignant neoplasm of overlapping sites of breast, female |
C50.811 | Malignant neoplasm of overlapping sites of right female breast |
C50.812 | Malignant neoplasm of overlapping sites of left female breast |
C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
C50.82 | Malignant neoplasm of overlapping sites of breast, male |
C50.821 | Malignant neoplasm of overlapping sites of right male breast |
C50.822 | Malignant neoplasm of overlapping sites of left male breast |
C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast |
C50.9 | Malignant neoplasm of breast of unspecified site |
C50.91 | Malignant neoplasm of breast of unspecified site, female |
C50.911 | Malignant neoplasm of unspecified site of right female breast |
C50.912 | Malignant neoplasm of unspecified site of left female breast |
C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
C50.92 | Malignant neoplasm of breast of unspecified site, male |
C50.921 | Malignant neoplasm of unspecified site of right male breast |
C50.922 | Malignant neoplasm of unspecified site of left male breast |
C50.929 | Malignant neoplasm of unspecified site of unspecified male breast |
C56 | Malignant neoplasm of ovary |
C56.1 | Malignant neoplasm of right ovary |
C56.2 | Malignant neoplasm of left ovary |
C56.9 | Malignant neoplasm of unspecified ovary |
C57.0 | Malignant neoplasm of fallopian tube |
C57.00 | Malignant neoplasm of unspecified fallopian tube |
C57.01 | Malignant neoplasm of right fallopian tube |
C57.02 | Malignant neoplasm of left fallopian tube |